What are the benefits of using metformin to reduce hyperglycemia in adults with T2DM?
Metformin has been demonstrated to reduce microvascular and macro vascular diabetes related outcomes by 32%, reduce the risk of myocardial infarction by 39%, reduce all-cause mortality rate by 36%, reduce hemoglobin A1c, weight, and improve ASCVD outcomes compared to sulfonylureas, and has an acceptable safety profile and low cost.